Paul Nghiem, MD, PhD, discusses individualized therapies and the evolving role of AI in improving outcomes for actinic keratosis and related skin conditions.

Actinic keratosis (AK) is a common precancerous lesion arising from cumulative ultraviolet exposure, often heralding the development of non-melanoma skin cancers such as basal cell carcinoma and ...

Over 58 million Americans have actinic keratosis, a skin condition caused by damage from the sun’s ultraviolet (UV) rays. With this condition, you develop scaly, discolored spots called actinic ...

Please provide your email address to receive an email when new articles are posted on . MIAMI BEACH, Fla. — Emerging treatments for actinic keratosis promise a brighter future for patients as phase 2 ...

The new approval allows for use of up to 3 tubes of Ameluz per treatment. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Ameluz ® (aminolevulinic acid ...

Sun Pharmaceutical Industries Limited ((IN:SUNPHARMA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — The treatment of actinic keratosis can be challenging. At the Maui Derm meeting, George M.

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...

Pharmacology: The mechanism of action by which ingenol mebutate induces cell death in treating actinic keratosis lesions is unknown. Clinical trials: In two double-blind, vehicle-controlled, clinical ...